Study your flashcards anywhere!

Download the official Cram app for free >

  • Shuffle
    Toggle On
    Toggle Off
  • Alphabetize
    Toggle On
    Toggle Off
  • Front First
    Toggle On
    Toggle Off
  • Both Sides
    Toggle On
    Toggle Off
  • Read
    Toggle On
    Toggle Off
Reading...
Front

How to study your flashcards.

Right/Left arrow keys: Navigate between flashcards.right arrow keyleft arrow key

Up/Down arrow keys: Flip the card between the front and back.down keyup key

H key: Show hint (3rd side).h key

A key: Read text to speech.a key

image

Play button

image

Play button

image

Progress

1/5

Click to flip

5 Cards in this Set

  • Front
  • Back
Fusion Inhibitors includes:
a.
Fusion Inhibitors includes:
a. Fuzeon (Enfuvirtide)
Fuzeon (Enfuvirtide)
mechanism of action:
Fuzeon (Enfuvirtide)
mechanism of action: BINDS TO GP-41 on HIV cell, thus BLOCKING THE BINDING OF HIV TO T-CELLS
Fuzeon (Enfuvirtide)
administration:
Fuzeon (Enfuvirtide)
administration: PEPTIDE STRUCTURE so must be given as SUBCUTANEOUS INJECTION
Fuzeon (Enfuvirtide)
adverse effects:
Fuzeon (Enfuvirtide)
adverse effects: local injection site reactions, pneumonia, hypersensitivity
Patient Education/Adherence
Monitoring Anti-Retroviral Therapy:
Patient Education/Adherence
Monitoring Anti-Retroviral Therapy: To assess adequacy of anti-retroviral therapy, patients should be monitored for status of immune function with T Cell analysis (# of CD4 cells) and concentration of HIV (viral load in copies/ml) in 4-6 weeks at the beginning of therapy, and then every 3 months afterward.